Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

類似資料

• Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass
  著者:: Anastasilakis, Athanasios D., 等
  出版事項: (2019)
• Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation
  著者:: Anastasilakis, Athanasios D., 等
  出版事項: (2020)
• Is Serum IL-17A a Useful Systemic Biomarker in Patients With Langerhans Cell Histiocytosis?
  著者:: Makras, Polyzois, 等
  出版事項: (2012)
• Deferasirox: appraisal of safety and efficacy in long-term therapy
  著者:: Chaudhary, Preeti, 等
  出版事項: (2013)
• A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis
  著者:: Miller, Paul D.
  出版事項: (2011)